2023_RDD_Europe_Antibes_May_leaderboard

Bert Dekens
Application Manager, Pharma

Hosokawa Micron BV

Is this your profile?

About

Bert Dekens is Application Manager, Pharma, for the Hosokawa Group, focusing on DPI blending markets. Mr Dekens holds a key position in the DPI network within the International Hosokawa Group and is well established in the DPI market.

Contributions

PRACTICAL INSIGHTS INTO LACTOSE-BASED DPI FORMULATIONS, WITH & WITHOUT MAGNESIUM STEARATE

Partners DFE Pharma, Hosokawa Micron and Harro Höfliger describe their unique multidisciplinary study into lactose-based DPI formulations including magnesium stearate, whose findings will give generic players a head-start in the development process so that they can tap into this rapidly growing market. The three companies announce that they will be presenting the key insights from their research to interested parties during a joint webinar on the June 30th, 2020.

More contributions

INDUSTRIALISATION

ONE-STOP SHOP FOR TOTAL MIXING SOLUTIONS FOR PHARMACEUTICAL MANUFACTURERS

Bert Dekens discusses Hosokawa Micron's offering for pharmaceutical powder mixing, including the Cyclomix high-shear mixer and the Nauta low-shear mixer, and how the company’s technology solutions take a broader approach to the full mixing process than simply providing a mixing machine.

A POSITIVE SPIN ON DPI FORMULATION

Bert Dekens outlines some of the considerations that go into developing and processing dry powder inhaler formulations, and discusses the merits of conical high-shear mixers.

FORMULATION METHODS & SIZE REDUCTION FOR INHALERS

Bert Dekens highlights the importance of achieving the correct particle sizes, both for the API and the carrier in formulations for inhalation, and describes some of the available equipment most suited to specific tasks.

Top